rethinkTHC Search
Menu
Study breakdown

CBD-Rich Cannabis Extract Improved Social Interaction in Children With Autism

Randomized Controlled TrialStrong evidence
The takeaway

In a randomized controlled trial of 60 children with autism, 12 weeks of CBD-rich cannabis extract significantly improved social interaction, anxiety, agitation, eating patterns, and concentration compared to placebo.

Autism researchers, pediatric neurologists, and families exploring ASD therapies

Social interaction improved significantly (p=0.0002)

What the researchers found

CBD-rich cannabis extract produced significant improvements in social interaction (p=0.0002), anxiety (p=0.016), psychomotor agitation (p=0.003), number of meals per day (p=0.04), and concentration (p=0.01, mild cases only). Only 9.7% of the treatment group experienced adverse effects (dizziness, insomnia, colic, weight gain), all mild.

Why it matters

This is one of the few randomized controlled trials examining CBD for autism in children. Social interaction, a core diagnostic criterion for ASD, showed the strongest improvement, suggesting CBD may address a fundamental challenge of the condition rather than just peripheral symptoms.

The numbers in context

60 children, ages 5-11. 12-week treatment. Social interaction: F=14.13, p=0.0002. Anxiety: F=5.99, p=0.016. Psychomotor agitation: F=9.22, p=0.003. Concentration improved only in mild cases (p=0.01). Adverse effects in 9.7% (3 children).

How the study worked

Randomized, double-blind, placebo-controlled clinical trial of 60 children aged 5-11 years with ASD. The treatment group received CBD-rich cannabis extract for 12 weeks. Outcomes were analyzed using two-factor mixed ANOVA.

What this study cannot tell us

Small sample (60 children). Single-center study. 12-week follow-up may not capture long-term effects. The concentration improvement was limited to mild ASD cases. Details on the specific CBD:THC ratio and dosing were limited in the abstract.

How to read the evidence

Randomized, double-blind, placebo-controlled design is the gold standard, though the small sample size and single center temper the strength.

When this study was published

2024 journal publication (submitted 2021)

The bigger picture

With ASD affecting 1 in 36 children and no pharmacological treatment for core symptoms, a well-tolerated intervention that improves social interaction is noteworthy. This trial, while small, adds to a growing evidence base for cannabinoid-based approaches to autism.

Questions still open

  • What is the optimal CBD dose and formulation for children with ASD? Do the improvements persist after stopping treatment? Would children with more severe ASD also benefit with longer treatment?

Common questions

Can CBD help children with autism?
This randomized trial of 60 children found CBD-rich cannabis extract significantly improved social interaction, anxiety, and agitation over 12 weeks. Only 3 children (9.7%) had mild side effects.
Which autism symptoms improved most with CBD?
Social interaction showed the strongest improvement (p=0.0002), followed by psychomotor agitation (p=0.003) and anxiety (p=0.016). Concentration improved only in children with milder autism.

Read the original research

Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial.

Trends in psychiatry and psychotherapy, 46, e20210396

Citation

Silva, Estácio Amaro da; Medeiros, Wandersonia Moreira Brito; Santos, João Paulo Mendes Dos; Sousa, João Marçal Medeiros de; Costa, Filipe Barbosa da; Pontes, Katiúscia Moreira; Borges, Thaís Cavalcanti; Espínola, Carlos; Andrade E Silva, Ana Hermínia; Nunes, Eliane Lima Guerra; Alves, Nelson Torro; Rosa, Marine Diniz da; Albuquerque, Katy Lísias Gondim Dias de. (2024). Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial.. Trends in psychiatry and psychotherapy, 46, e20210396. https://doi.org/10.47626/2237-6089-2021-0396

Explore the wider topic